| Open Document File Size: 3,69 MBShare Result on Facebook
City Reference / / Company LEO Pharma Inc. / Applicant Leo Pharmaceuticals Ltd / / Continent Europe / / Country United States / / Event FDA Phase / / Facility Laboratory Assessments / Laboratory Findings / / IndustryTerm Treatment of Psoriasis / study product / / MedicalCondition disease / headache / gastroenteritis / plaque psoriasis / tinea / least moderate psoriasis / Controlled Disease / lymphadenopathy / tension headache / Psoriasis / cough / pruritus / rash / Ointment Therapeutic Class Psoriasis / upper respiratory tract infection / / Organization FDA / Advisory Committee / MD NDA / / Person McCord Review / / Position Investigator / / Product Taclonex / Calcipotriene / betamethasone dipropionate / S-15 / Taclonex® / psoriasis / Taclonex ® Ointment / / Technology Pharmacokinetics / Pharmacodynamics / /
SocialTag |